Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue

被引:309
作者
Halleux, CM
Takahashi, M
Delporte, ML
Detry, R
Funahashi, T
Matsuzawa, Y
Brichard, SM
机构
[1] Univ Louvain, Fac Med, Endocrinol & Metab Unit, Brussels, Belgium
[2] Univ Louvain, Fac Med, Surg Unit, Brussels, Belgium
[3] Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, Osaka, Japan
关键词
adipose tissue; adipocyte secretory protein; adiponectin; apM1; obesity; metabolic syndrome; insulin; IGF1; glucocorticoids;
D O I
10.1006/bbrc.2001.5904
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adiponectin (ApN) is thought to play a major role in the pathogenesis of the Metabolic Syndrome. Production of ApN and regulation of its related gene (apM1) have not yet been studied in human visceral adipose tissue. ApN was mainly associated with adipocyte membranes and abundantly secreted in medium from isolated adipocytes. apM1 gene expression, restricted to the adipocyte fraction of adipose tissue, decreased spontaneously when adipose explants were cultured in basal medium for 24 h while the expression of other adipose genes barely changed (PPAR gamma, GAPDH) or increased (PAI-1). Unexpectedly, the fall of apM1 mRNA was prevented by the addition of actinomycin D, an inhibitor of transcription, or cycloheximide, an inhibitor of protein synthesis, and by reducing the amount of adipose tissue cultured per dish, thereby suggesting that a newly synthesized factor released by adipose tissue destabilizes apM1 mRNA. apM1 gene expression was also negatively regulated by glucocorticoids and positively by insulin and IGF-1. This regulation could contribute to the decreased apMl/ApN levels in insulin-resistant patients with obesity and the Metabolic Syndrome. (C) 2001 Academic Press.
引用
收藏
页码:1102 / 1107
页数:6
相关论文
共 25 条
  • [1] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
    Arita, Y
    Kihara, S
    Ouchi, N
    Takahashi, M
    Maeda, K
    Miyagawa, J
    Hotta, K
    Shimomura, I
    Nakamura, T
    Miyaoka, K
    Kuriyama, H
    Nishida, M
    Yamashita, S
    Okubo, K
    Matsubara, K
    Muraguchi, M
    Ohmoto, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 79 - 83
  • [2] The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
    Berg, AH
    Combs, TP
    Du, XL
    Brownlee, M
    Scherer, PE
    [J]. NATURE MEDICINE, 2001, 7 (08) : 947 - 953
  • [3] Bjorntorp P, 1997, DIABETES REV, V5, P52
  • [4] Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4
    Bogan, JS
    Lodish, HF
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 146 (03) : 609 - 620
  • [5] Does central obesity reflect ''Cushing's disease of the omentum''?
    Bujalska, IJ
    Kumar, S
    Stewart, PM
    [J]. LANCET, 1997, 349 (9060) : 1210 - 1213
  • [6] DECAUX JF, 1989, J BIOL CHEM, V264, P11584
  • [7] FRIED SK, 1998, HDB OBESITY, P397
  • [8] Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
    Fruebis, J
    Tsao, TS
    Javorschi, S
    Ebbets-Reed, D
    Erickson, MRS
    Yen, FT
    Bihain, BE
    Lodish, HF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) : 2005 - 2010
  • [9] Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue:: Increased responsiveness to glucocorticoids in obesity
    Halleux, CM
    Servais, I
    Reul, BA
    Detry, R
    Brichard, SM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) : 902 - 910
  • [10] Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: Stimulation by glucocorticoids and inhibition by catecholamines
    Halleux, CM
    Declerck, PJ
    Tran, SL
    Detry, R
    Brichard, SM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) : 4097 - 4105